Tower Research Capital LLC (TRC) - RIGEL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,659
-61.9%
9,869
-54.5%
0.00%
-100.0%
Q2 2023$27,985
+174806.2%
21,694
+78.1%
0.00%0.0%
Q1 2023$16
-33.3%
12,180
-24.8%
0.00%0.0%
Q4 2022$24
-99.9%
16,188
-50.8%
0.00%0.0%
Q3 2022$39,000
-68.5%
32,878
-70.1%
0.00%
-66.7%
Q2 2022$124,000
+55.0%
109,944
+314.7%
0.00%
+200.0%
Q1 2022$80,000
-50.6%
26,512
-56.7%
0.00%
-66.7%
Q4 2021$162,000
+33.9%
61,234
+82.8%
0.00%0.0%
Q3 2021$121,000
+120.0%
33,491
+160.8%
0.00%
+200.0%
Q2 2021$55,000
-5.2%
12,840
-25.2%
0.00%0.0%
Q1 2021$58,000
+52.6%
17,157
+57.9%
0.00%0.0%
Q4 2020$38,000
-93.1%
10,863
-95.2%
0.00%
-83.3%
Q3 2020$547,000
+728.8%
227,819
+528.7%
0.01%
+100.0%
Q2 2020$66,00036,236
+47578.9%
0.00%
Q4 2019$0
-100.0%
76
-94.4%
0.00%
Q3 2019$3,0001,364
+1768.5%
0.00%
Q2 2019$073
-47.9%
0.00%
Q1 2019$0
-100.0%
140
-99.3%
0.00%
-100.0%
Q2 2018$56,000
+75.0%
19,584
+116.2%
0.00%0.0%
Q1 2018$32,000
-34.7%
9,059
-53.3%
0.00%
-25.0%
Q3 2017$49,000
+36.1%
19,383
+18.8%
0.00%
+33.3%
Q2 2016$36,000
+24.1%
16,314
+38.4%
0.00%0.0%
Q3 2015$29,000
+314.3%
11,791
+416.9%
0.00%
+200.0%
Q2 2015$7,000
-88.9%
2,281
-87.2%
0.00%
-87.5%
Q1 2015$63,000
+43.2%
17,751
-22.3%
0.01%
+60.0%
Q3 2014$44,00022,832
+48478.7%
0.01%
Q2 2014$0
-100.0%
47
-98.9%
0.00%
-100.0%
Q4 2013$12,000
+1100.0%
4,321
+2426.9%
0.00%
Q3 2013$1,000
-85.7%
171
-91.5%
0.00%
-100.0%
Q2 2013$7,0002,0150.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders